• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴大血管侵犯的肝细胞癌:多模态影像学特征的诊断价值。

Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis.

机构信息

Department of Radiology - BiND, University Hospital "Paolo Giaccone", Palermo, Italy.

Department of Radiology, AP-HP, Hôpital Beaujon, Clichy, Hauts-de-Seine, France;INSERM U1149 "centre de recherche sur l'inflammation", Université de Paris, Paris, France.

出版信息

Diagn Interv Radiol. 2020 Nov;26(6):531-540. doi: 10.5152/dir.2020.19569.

DOI:10.5152/dir.2020.19569
PMID:32990243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7664740/
Abstract

Hepatocellular carcinoma (HCC) is frequently associated with macrovascular invasion of the portal vein or hepatic veins in advanced stages. The accurate diagnosis of macrovascular invasion and the differentiation from bland non-tumoral thrombus has significant clinical and management implications, since it narrows the therapeutic options and it represents a mandatory contraindication for liver resection or transplantation. The imaging diagnosis remains particularly challenging since the imaging features of HCC with macrovascular invasion may be subtle, especially in lesions showing infiltrative appearance. However, each radiologic imaging modality may provide findings suggesting the presence of tumor thrombus rather than bland thrombus. The purpose of this paper is to review the current guidelines and imaging appearance of HCC with macrovascular invasion. Knowledge of the most common imaging features of HCC with macrovascular invasion may improve the diagnostic confidence of tumor thrombus in clinical practice and help to guide patients' management.

摘要

肝细胞癌(HCC)在晚期常伴有门静脉或肝静脉的大血管侵犯。准确诊断大血管侵犯并将其与良性非肿瘤性血栓区分开来具有重要的临床和管理意义,因为这会缩小治疗选择范围,并且是肝切除术或肝移植的强制性禁忌证。由于大血管侵犯的 HCC 的影像学特征可能不明显,尤其是表现为浸润性外观的病变,因此影像学诊断仍然具有特别大的挑战性。然而,每种影像学检查方法都可能提供提示肿瘤血栓而不是良性血栓存在的发现。本文旨在回顾大血管侵犯的 HCC 的现行指南和影像学表现。了解大血管侵犯的 HCC 的最常见影像学特征可以提高临床实践中对肿瘤血栓的诊断信心,并有助于指导患者的管理。

相似文献

1
Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis.伴大血管侵犯的肝细胞癌:多模态影像学特征的诊断价值。
Diagn Interv Radiol. 2020 Nov;26(6):531-540. doi: 10.5152/dir.2020.19569.
2
Too Big to Fail: Successful Resection of a Large Hepatocellular Carcinoma with Portal Tumor Thrombus.大而不能倒:成功切除伴有门静脉癌栓的大型肝细胞癌
Dig Dis Sci. 2021 Jun;66(6):1797-1801. doi: 10.1007/s10620-020-06682-9. Epub 2020 Nov 3.
3
Portal vein thrombus and infiltrative HCC: a pictoral review.门静脉血栓与浸润性肝癌:影像学综述。
Abdom Radiol (NY). 2017 Jan;42(1):159-170. doi: 10.1007/s00261-016-0855-z.
4
Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy.肝癌切除术治疗的放射预后因子。
Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):612-7. doi: 10.1016/s1499-3872(12)60232-x.
5
Living donor liver transplantation to a survivor of liver resection for hepatocellular carcinoma with major portal vein invasion.活体肝移植给一名肝细胞癌伴门静脉主干侵犯行肝切除术后的幸存者。
Acta Med Okayama. 2013;67(2):117-21. doi: 10.18926/AMO/49671.
6
Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI.浸润性肝细胞癌的良恶性模拟病变:CT 和 MRI 鉴别诊断的技巧。
Clin Imaging. 2021 Feb;70:33-45. doi: 10.1016/j.clinimag.2020.10.011. Epub 2020 Oct 15.
7
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
8
Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.鉴别肝癌肝移植候选者肿瘤与非肿瘤性门静脉血栓:A-VENA 标准。
Liver Transpl. 2019 Feb;25(2):207-216. doi: 10.1002/lt.25345.
9
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
10
Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes.中国肝细胞癌的外科治疗:手术技术、适应证及治疗效果
Langenbecks Arch Surg. 2005 Jun;390(3):259-65. doi: 10.1007/s00423-005-0552-9. Epub 2005 May 4.

引用本文的文献

1
Efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma with macrovascular invasion: a single-center retrospective analysis.联合肝脏离断和门静脉结扎的二步肝切除术(ALPPS)治疗伴有大血管侵犯的肝细胞癌的疗效:一项单中心回顾性分析。
World J Surg Oncol. 2024 Sep 28;22(1):260. doi: 10.1186/s12957-024-03538-8.
2
Refining MRI-based criteria for portal vein invasion in hepatocellular carcinoma: improving sensitivity beyond portal vein tumor thrombosis.细化基于 MRI 的肝细胞癌门静脉侵犯标准:提高超越门静脉癌栓的敏感性。
Abdom Radiol (NY). 2024 Feb;49(2):437-446. doi: 10.1007/s00261-023-04106-6. Epub 2023 Nov 21.
3
A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus.索拉非尼、免疫检查点抑制剂、经动脉化疗栓塞术(TACE)和立体定向体部放射治疗联合应用与索拉非尼和TACE治疗伴门静脉癌栓的晚期肝细胞癌的疗效比较
Cancers (Basel). 2022 Jul 25;14(15):3619. doi: 10.3390/cancers14153619.
4
Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter.高危患者肝细胞癌诊断相关的临床因素与影像学因素:大小很重要。
Future Sci OA. 2022 Feb 2;8(4):FSO785. doi: 10.2144/fsoa-2021-0108. eCollection 2022 Apr.
5
Hepatocellular Carcinoma in 2021: An Exhaustive Update.2021年肝细胞癌:详尽的最新进展
Cureus. 2021 Nov 5;13(11):e19274. doi: 10.7759/cureus.19274. eCollection 2021 Nov.
6
Cysteine-rich intestinal protein 1 enhances the progression of hepatocellular carcinoma via Ras signaling.富含半胱氨酸的肠蛋白 1 通过 Ras 信号促进肝癌的进展。
Kaohsiung J Med Sci. 2022 Jan;38(1):49-58. doi: 10.1002/kjm2.12445. Epub 2021 Sep 29.
7
Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study.索拉非尼、卡瑞利珠单抗、经动脉化疗栓塞术和立体定向体部放疗联合应用作为伴有门静脉癌栓的晚期肝细胞癌的一种新型降期策略:一项病例系列研究
Front Oncol. 2021 Aug 2;11:650394. doi: 10.3389/fonc.2021.650394. eCollection 2021.

本文引用的文献

1
Current concepts in portal vein thrombosis: etiology, clinical presentation and management.门静脉血栓形成的当前概念:病因、临床表现和治疗。
Abdom Radiol (NY). 2019 Oct;44(10):3453-3462. doi: 10.1007/s00261-019-02174-1.
2
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.2018 韩国肝癌协会-韩国国家癌症中心肝细胞癌管理实践指南。
Gut Liver. 2019 May 15;13(3):227-299. doi: 10.5009/gnl19024.
3
Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?肝细胞癌的超声造影:我们目前的进展如何?
Ultrasonography. 2019 Jul;38(3):200-214. doi: 10.14366/usg.18060. Epub 2019 Feb 25.
4
Value of F-FDG PET/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma.F-FDG PET/CT 在肝细胞癌患者门静脉癌栓诊断中的价值。
Abdom Radiol (NY). 2019 Jul;44(7):2430-2435. doi: 10.1007/s00261-019-01997-2.
5
All about portal vein: a pictorial display to anatomy, variants and physiopathology.门静脉全解:门静脉解剖、变异及病理生理学的图文展示
Insights Imaging. 2019 Mar 21;10(1):38. doi: 10.1186/s13244-019-0716-8.
6
Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.基于增强 CT 的影像组学分析预测肝细胞癌的微血管侵犯及预后
J Hepatol. 2019 Jun;70(6):1133-1144. doi: 10.1016/j.jhep.2019.02.023. Epub 2019 Mar 13.
7
Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.肝细胞癌(HCC)与非 HCC:肝脏影像报告和数据系统 v2018 的准确性和可靠性。
Abdom Radiol (NY). 2019 Jun;44(6):2116-2132. doi: 10.1007/s00261-019-01948-x.
8
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.肝脏影像报告和数据系统(LI-RADS):从其起源到最近纳入美国肝病研究学会(AASLD)临床实践指南的概念与历史回顾
J Hepatocell Carcinoma. 2019 Feb 5;6:49-69. doi: 10.2147/JHC.S186239. eCollection 2019.
9
Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis.钆塞酸增强 MRI 影像学组学分析用于肝纤维化分期。
Radiology. 2019 Feb;290(2):380-387. doi: 10.1148/radiol.2018181197. Epub 2018 Dec 4.
10
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?肝细胞癌患者门静脉癌栓的范围:越多,越差?
Liver Int. 2019 Feb;39(2):324-331. doi: 10.1111/liv.13988. Epub 2018 Nov 9.